ZA77943B - Topical steroid clindamycin preparations - Google Patents

Topical steroid clindamycin preparations

Info

Publication number
ZA77943B
ZA77943B ZA770943A ZA77943A ZA77943B ZA 77943 B ZA77943 B ZA 77943B ZA 770943 A ZA770943 A ZA 770943A ZA 77943 A ZA77943 A ZA 77943A ZA 77943 B ZA77943 B ZA 77943B
Authority
ZA
South Africa
Prior art keywords
clindamycin
preparations
topical steroid
steroid
topical
Prior art date
Application number
ZA770943A
Inventor
G Flynn
D Ayer
C Schlagel
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/668,389 external-priority patent/US4018918A/en
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of ZA77943B publication Critical patent/ZA77943B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0069Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • C07J5/0076Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60Sugars; Derivatives thereof
    • A61K8/602Glycosides, e.g. rutin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63Steroids; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/12Aerosols; Foams
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
ZA770943A 1976-03-19 1977-02-16 Topical steroid clindamycin preparations ZA77943B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/668,389 US4018918A (en) 1975-05-20 1976-03-19 Topical clindamycin preparations

Publications (1)

Publication Number Publication Date
ZA77943B true ZA77943B (en) 1977-12-28

Family

ID=24682131

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA770943A ZA77943B (en) 1976-03-19 1977-02-16 Topical steroid clindamycin preparations

Country Status (7)

Country Link
JP (1) JPS52113954A (en)
BE (1) BE852649R (en)
DE (1) DE2710880A1 (en)
FR (1) FR2344288A2 (en)
GB (1) GB1527061A (en)
NL (1) NL7702822A (en)
ZA (1) ZA77943B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05501115A (en) * 1990-03-27 1993-03-04 シェリング・コーポレーション 9α-Hydroxy steroid dehydration method
JP2648886B2 (en) * 1990-10-30 1997-09-03 日本曹達株式会社 How to Prevent Household Mastitis
US6214318B1 (en) 1997-10-02 2001-04-10 Oms Holdings Llc Aerosol ointment compositions for topical use
ATE257372T1 (en) * 1997-10-02 2004-01-15 Oms Holdings Llc AEROSOL OINTMENT PREPARATIONS

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1403962A (en) * 1972-03-09 1975-08-28 Upjohn Co Anti-inflammatory pregnane derivative

Also Published As

Publication number Publication date
FR2344288A2 (en) 1977-10-14
JPS52113954A (en) 1977-09-24
NL7702822A (en) 1977-09-21
DE2710880A1 (en) 1977-09-29
FR2344288B2 (en) 1980-04-04
GB1527061A (en) 1978-10-04
BE852649R (en) 1977-09-19

Similar Documents

Publication Publication Date Title
AU519231B2 (en) Heparin-liposomes complex
AU511270B2 (en) Topical spray
PH12183A (en) Steroid composition for topical application
JPS5336285A (en) Spectrometer
JPS5346091A (en) Chromatograph
AU1516776A (en) Tooch preparations
JPS5285159A (en) Novel steroid compound
ZA776311B (en) Improved ointment
GB1557645A (en) Enzyme preparations
AU507804B2 (en) Topical steroid formulations
JPS5350364A (en) Enzyme preparations
GB1539062A (en) 7-dehydrocholesterol derivatives
AU504800B2 (en) Gas-cable junction
JPS5350152A (en) Pregnane derivatives
JPS5224096A (en) Superconductor
JPS52148062A (en) Steroids
AU512101B2 (en) 19-oxygenated steroids
ZA77943B (en) Topical steroid clindamycin preparations
JPS51130425A (en) Colddwaterrsoluble preparations
GB1541710A (en) Anthelintic preparations
AU507072B2 (en) Reducing zeearalenone
JPS52117177A (en) Spectrometer
JPS5365145A (en) Designal auxiliary aid
AU505624B2 (en) B-homo steroids
AU502977B2 (en) Valve structure